In vitro cellular level - PharmaCore Labs (PCL) Co., Ltd

SERVICE

KEYWORD

CONTACT US

Main Office, PCL

Address: Haimen Biotech and Pharmaceutical Park, Riverside New District, Haimen, Jiangsu Province, China

Tel:+86 0513 68015200

Email:infor@pharmacorelab.com
Website: www.pharmacorelab.com


Branch Office, PCL

Address: Block 6D, 780 Cailun Road, China (Shanghai) pilot free trade zone. infor@pharmacorelab.com

In vitro cellular level

Your current location: Home > SERVICE > Preclinical cardiac safety > In vitro cellular level

iPS-derived cardiomycytes

Time2020-04-20 15:29:55 Hits767


CiPA program requires drug's effect on cardiac ion channels and action potential to be verified in human ventricular iPS (induced pluropotent stem cell)-derived myocytes.

In vitro electrophysiology assay in human iPS-derived ventricular myocytes:

Assay platform/method

Conventional patch clamp

Cells used in the assay

Human iPS-derived ventricular myocytes( IPSC)

Measured parameters

Action potential (APA, APD30/60/90)

Test concentrations

3 doses, 3 stimulation frequency (0.5 Hz, 1 Hz, 1.7 Hz)

Data point repeats

N = 3 for each concentration

Note: 1) Positive control: 0.3 μM Haloperidol is used in the assay to ensure cell quality and normal response of sodium channels.

2) If requested, 1 or 2 stimulation frequency can be selected.



Effect of haloperidol on IPS-derived ventricular myocytes

Effect of terfenadine on IPS-derived ventricular myocytes

Copyright © PharmaCore Labs (PCL) Co., Ltd All rights reserved 备案号:苏ICP备15051795号 欢迎来电咨询! 技术支持:裕福科技